CPAP 治疗对严重不受控制的哮喘患者的影响:ASTHMA-SLEEP 试验
CPAP 治疗对严重不受控制的哮喘和阻塞性睡眠呼吸暂停患者哮喘控制的影响:ASTHMA-SLEEP 试验
The aim of the study is to evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and obstructive sleep apnea (OSA)
研究概览
详细说明
Background: The prevalence of obstructive sleep apnea (OSA) is high in patients with severe uncontrolled asthma and can worsen asthma control. Previous observational studies demonstrated that CPAP treatment could improve control in patients with mild-moderate asthma. Nevertheless, there are no studies in patients with severe uncontrolled asthma.
Primary objective: To evaluate the impact of CPAP treatment on asthma control in patients with severe uncontrolled asthma and OSA.
Methodology: Multicenter, prospective, randomized, controlled clinical trial with parallel groups in subjects with severe uncontrolled asthma who are older than 18 years and without sleepiness (Epworth sleepiness scale score ≤10). All included subjects will undergo conventional polysomnography and those with an apnea-hypopnea index (AHI) ≥15/hour will be randomized in a 1:1 ratio to receive conservative treatment or conservative treatment plus CPAP. Monitoring will be carried out during12 months. Patients will be evaluated at inclusion, at 1 month, 6 and 12 months.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Mireia Dalmases, MD
- 电话号码:+34932275746
- 邮箱:mdalmase@clinic.cat
学习地点
-
-
Spain
-
Barcelona、Spain、西班牙、08036
- 招聘中
- Hospital Clinic Barcelona
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age >18 years
- Diagnosis of severe uncontrolled asthma according to the criteria of the Spanish Asthma Management Guide (GEMA) or the Global Initiative for Asthma (GINA) and no hospitalizations the month prior to inclusion in the study.
- Apnea hypopnea rate greater than or equal to 15/hour
- Punctuation in the Epworth Sleepiness Scale ≤10
- Obtaining informed consent.
Exclusion Criteria:
- Previous treatment with CPAP
- Patient with central sleep apnea or Cheyne-Stokes respiration
- Other sleep disorders: narcolepsy, restless leg syndrome, chronic insomnia,
- Resistant hypertension
- Active Smoking
- Unstable comorbidities or medications may interfere with asthma control
- Pregnancy
- Any process that reduces life expectancy to <1 year,
- Any medical or social factor that may limit CPAP compliance
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Conservative treatment
Subjects allocated to this arm will receive hygienic and dietary measures counselling |
Subjects allocated to this arm will receive hygienic and dietary counselling |
|
实验性的:CPAP treatment
Subjects allocated to this arm will receive treatment with continuous positive airway pressure (CPAP) |
Subjects allocated to this arm will receive continuous positive airway pressure (CPAP) |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Asthma control questionnaire
大体时间:12 months
|
To evaluate the impact of CPAP treatment on asthma control based on the Asthma control questionnaire (ACQ) |
12 months
|
|
Asthma control test
大体时间:12 months
|
To evaluate the impact of CPAP treatment on asthma control based on the Asthma control test (ACT) |
12 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Lung function- forced expiratory volume in the first second (FEV1) in spirometry
大体时间:12 months
|
To evaluate the impact of CPAP treatment on FEV1 (ml) on spirometry |
12 months
|
|
Lung function-forced vital capacity (FVC) in spriometry
大体时间:12 months
|
To evaluate the impact of CPAP treatment on FVC (ml) on spirometry |
12 months
|
|
Prevalence of OSA in severe uncontrolled asthma
大体时间:Baseline
|
Determine the prevalence of OSA in patients with severe uncontrolled asthma |
Baseline
|
|
Inflammatory profile
大体时间:Baseline, 6 and 12 months
|
Plasma proteins from peripheral blood samples will be used to analyze an inflammatory panel using a high-throughput, multiplex immunoassay technology based on Proximity Extension Assays (PEA) at baseline and after CPAP treatment |
Baseline, 6 and 12 months
|
|
Quality of life (Abbreviated Asthma Quality of life Questionnaire- mini-AQLQ questionnaire)
大体时间:12 months
|
Study whether OSA ans its treatment affects quality of life in subjects with severe uncontrolled asthma based on the punctuation obtained in the mini-AQLQ questionnaire. Higher scores indicate better quality of life |
12 months
|
|
Exacerbations
大体时间:From enrollment to the end of the study at 12 months
|
Number of excarbations the year before starting the study and at 12-month of treatment in both arms |
From enrollment to the end of the study at 12 months
|
合作者和调查者
调查人员
- 首席研究员:Mireia Dalmases, MD、Hospital Clinic
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- HCB/2022/1204
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Anonymized IPD will be available upon reasonable request following publication of the study results. Requests will be valuated by the study team and be subject to applicable ethical, legal and data portection requeriments.
IPD 共享时间框架
IPD will be available upon reasonable request following publication of the study results.
IPD 共享访问标准
Access will be granted to qualified researchers for cientifically valid reserach purposes
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.